505(b)(2): It’s A Different Animal
Camargo
Hot Topics > Consolidation
Consolidation
The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
PRA says Clinstar Takeover Offers Quicker and Cheaper Patient Enrollment
05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
Quintiles and TPG tight-lipped on latest IPO rumours
29-Jan-2013 - Quintiles and investor TPG Capital declined to comment on rumours the CRO is sizing up banks and preparing for an IPO.
Medpace boost EU device offering through Meditech takeover
20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.
CRO round-up: collaboration, expansions and small providers teaming-up to take on the big players
14-Nov-2012 - A new personalised medicine-focused partnership for AstraZeneca, expansion in three continents for World Wide clinical and six small CROs team-up to create one super-team. Outsourcing-pharma.com presents a round-up of the...
UPDATE
PCT Europe 2012: Managing risk, emerging markets and industry criticism
08-Nov-2012 - Outsourcing-Pharma.com is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.
Is Eli Lilly distancing itself from outsourcing?
05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.
News from AAPS
Xcelience plans EU clinical trial supply expansion after opening new US plant
23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
Piramal looking for injectables capacity at the right price
15-Oct-2012 - Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
Clinipace doubles in size after purchase of Paragon
25-Sep-2012 - Clinipace has bought Californian CRO Paragon Biomedical in a bid to expand its therapeutic expertise.
News in brief
Carestream sells preclinical imaging biz to Bruker
24-Sep-2012 - Carestream Health has offloaded most of its preclinical molecular imaging systems in a deal with Bruker.
Quintiles grants "prime site" status to Comprehensive
20-Sep-2012 - Quintiles has granted Comprehensive Clinical Development first refusal to work on its sponsored clinical trials.
News in brief
Eckert & Ziegler boosts early phase offering with Vitalea Science takeover
11-Sep-2012 - Isotope technology firm Eckert & Ziegler has acquired bioanalytical CRO Vitalea Science.
Improving Biopharma R&D efficiency a mixed blessing for CROs
06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.
Contract manufacturing news round-up
05-Sep-2012 - Outsourcing-Pharma.com presents a round-up of the latest from the world of contract manufacturing, including extensive jobs cuts for Merck, a monoclonal antibody agreement for Cobra and Algeta and Aesica’s latest...
Charles River buys Accugenix to boost microbial testing
29-Aug-2012 - Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
Market access teams should have more influence in clinical trial design, say Cutting Edge Information
28-Aug-2012 - Health economics and outcomes research teams must have a greater influence over clinical trial design if pharma firms are to achieve reimbursement goals, according to Cutting Edge Information.
New pharma services from M&A and partnerships: round-up
07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...
AstraZeneca and Assay Depot's VRM allows full drug discovery from a laptop
01-Aug-2012 - AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop....
UPDATE
All Indian pharmaceutical CMOs must pay the excise duty, says SPIC
23-Jul-2012 - SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.
BioFocus gives itself room to update compound library
17-Jul-2012 - BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.
No cuts at DPT Labs says new owner Renaissance Pharma
09-Jul-2012 - No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.
iGATE says new data management tech will change R&D
09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
EXCLUSIVE
CDMO and CRO must become one so clinical research can evolve: Quotient.
05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.
UPDATE
Cut in-house R&D and increase outsourcing, says GBI
03-Jul-2012 - Cutting in-house R&D staff to outsource more activities cuts will drive the industry forward, according to a new report.
Skills shortage to drive M&A at big CROs, analyst predicts
28-Jun-2012 - A shortage of staff to serve strategic deals will drive big CROs to scale and consolidate through M&A, an analyst predicts.
